A web platform to facilitate and speed up
the implementation of Quality-by-Design
studies in Drug and Medical Device
TBMED is an EU-funded collaborative research project which aims to increase patients’ access to high-risk medical
devices, by helping SMEs to minimize time-to-market and the reimbursement process time, thus optimizing the process
of transforming a prototype into a valuable innovative MD.
EXPERT aims at developing a new off-the-shelf delivery system for RNA-based nanomedicines to treat cancer and cardiovascular disease.
In the long term, the platform technology could be used for improving diagnostic and therapeutic options for patients with several other diseases.
What is Quality-by-Design ?
Quality by design (QbD) is a proactive & holistic approach that begins with the end in mind and includes a Risk-Based Managment process in which products or processes are scientifically designed to meet specific objectives.
Why easyQbD ?
easyQbD is a supervised service to facilitate and speed-up the development of drugs and medical devices. It has been specifically designed to assist partners in collaborative projects. Users are assisted by biostatisticians for the design of their experiments and the data analysis.
How does it work ?
easyQbD is a secured web-based platform that automatically guides non-experts through the QbD workflow. Each user has its login and password to access easyQbD.
easyQbD in Scientific projects:
- EXPERT (2019-2024) EXpanding Platforms for Efficacious mRNA Therapeutics, H2020 project.
- TBMED (2019-2023) A testing bed for the development of high-risk medical devices.
- M3ODALIty (2017-2020) Modular, Multivalent and Multiplexed tOols for DuAl moLecular Imaging, ANR project.
- NanoBiT (2016-2019), Nanoscintillator-Porphyrin Complexes for Bimodal RadioPhotoDynamic Therapy, EuroNanoMed II project.